lobbying_filings_raw: d5a2b2a1-bf3d-4442-85dd-3e28a25aec20

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API. Sortable columns (indexed): filing_type, client_name, filing_year, client_state, registrant_state, registrant_house_id, registrant_id. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence income_amount expense_amount
d5a2b2a1-bf3d-4442-85dd-3e28a25aec20 Q2 62778 RICCHETTI INCORPORATED 162105 EISAI, INC. 2018 second_quarter 2018-07-18T14:45:02.160000-04:00 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/d5a2b2a1-bf3d-4442-85dd-3e28a25aec20/", "filing_uuid": "d5a2b2a1-bf3d-4442-85dd-3e28a25aec20", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2018, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/d5a2b2a1-bf3d-4442-85dd-3e28a25aec20/print/", "filing_document_content_type": "text/html", "income": "30000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Peter Kiefhaber", "dt_posted": "2018-07-18T14:45:02.160000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "601 13th Street, NW", "registrant_address_2": "Suite 1150 North", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 62778, "url": "https://lda.senate.gov/api/v1/registrants/62778/", "house_registrant_id": 35395, "name": "RICCHETTI INCORPORATED", "description": "Lobbying and consulting", "address_1": "601 13th Street, NW", "address_2": "Suite 830N", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "JEFF RICCHETTI", "contact_telephone": "+1 202-879-9382", "dt_updated": "2026-01-27T10:45:34.009702-05:00"}, "client": {"id": 162105, "url": "https://lda.senate.gov/api/v1/clients/162105/", "client_id": 1004758, "name": "EISAI, INC.", "general_description": "Pharmaceutical company.", "client_government_entity": false, "client_self_select": null, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2015-04-01"}, "lobbying_activities": [{"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "Issues regarding the validity of patents following transactions involving aspects of prior art.", "foreign_entity_issues": "Eiasi Inc, is owned by Eiasi Co., Ltd. (Tokyo, Japan) and to the degree that public policies, either laws or regulations, commercially benefit Eiasi, Inc, so to Eiasi Co., Ltd., as the parent company, will benefit.", "lobbyists": [{"lobbyist": {"id": 30648, "prefix": null, "prefix_display": null, "first_name": "JEFF", "nickname": null, "middle_name": null, "last_name": "RICCHETTI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Issues related to coverage of obesity drugs under Federal health care programs.", "foreign_entity_issues": "Eiasi Inc, is owned by Eiasi Co., Ltd. (Tokyo, Japan) and to the degree that public policies, either laws or regulations, commercially benefit Eiasi, Inc, so to Eiasi Co., Ltd., as the parent company, will benefit.", "lobbyists": [{"lobbyist": {"id": 30648, "prefix": null, "prefix_display": null, "first_name": "JEFF", "nickname": null, "middle_name": null, "last_name": "RICCHETTI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Issues related to the treatment of obesity.", "foreign_entity_issues": "Eiasi Inc, is owned by Eiasi Co., Ltd. (Tokyo, Japan) and to the degree that public policies, either laws or regulations, commercially benefit Eiasi, Inc, so to Eiasi Co., Ltd., as the parent company, will benefit.", "lobbyists": [{"lobbyist": {"id": 30648, "prefix": null, "prefix_display": null, "first_name": "JEFF", "nickname": null, "middle_name": null, "last_name": "RICCHETTI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 35395 DC DC US US Pharmaceutical company. 0 0         30000.0  

Links from other tables